Purchase Order HHSN272201400734P
Award Date 7/17/14
Potential Completion Date 12/31/14
Potential Value $31K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This $30,600.00 Firm Fixed Price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization, for HIV infected patient screening, interviewing, and follow-up services. The contract has an ultimate completion date of January 8, 2016 and was awarded on May 8, 2015. This contract is not associated with a set-aside program.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a $52,700.00 firm fixed price purchase order to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization, to provide HIV patient screening, collection of specimens, and gathering of medical history for 24 pre-determined patients over the period from August 1, 2019 to December 31, 2019. This sole source award was made under the...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization. The $40,800.00 firm fixed price contract is for HIV patient screening, collection of specimens, and gathering of medical history. The place of performance is in Ottawa, Ontario, Canada, and the completion date was August 14, 2018. No set-aside...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
- <p>This is a $40,800.00 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization, for human cell enrichment kits. The contract has a completion date of December 31, 2018 and does not utilize any set-aside designations. The place of performance is located in Ottawa, Ontario, Canada.</p>
- This federal contract award, with an ID of 75N91019D00024|75N91019F00137, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $9,235,930.00 cost-plus-fixed-fee contract was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to complete HIV studies intended to describe the characteristics, course, and treatment response of HIV disease in the study population. The...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...
- The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services (HHS), to Aalto Bio Reagents Limited, a for-profit limited liability company. The award, valued at $9,204.00, is for the purchase of 13 vials of 2 mg each of "AFFINITY PURIFIED SHEEP ANTI-HIV-1-GP120" at $728.00 per vial. The contract has a firm fixed price and an ultimate completion date of March 31, 2014. The...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $254,076.51 cost-plus-fixed-fee delivery order contract was awarded to Southern Research Institute, a non-profit organization that provides advanced drug discovery and development services. The contract supports high-throughput screening to identify HIV inhibitors as part of NIAID's "In Vitro Testing...